Effect of eight weeks of single-blind clinical trial of aerobic exercise with green coffee consumption on Follistatin and Myostatin plasma in non-athlete and overweight women

Authors
1 Department of exercise physiology, Neyshabur branch, Islamic Azad University, Neyshabur, Iran
2 Department of exercise physiology, Ferdowsi University of Mashhad, Mashhad, Iran
3 Department of exercise physiology, Mashhad branch, Islamic Azad University, Mashhad, Iran
Abstract
Introduction: Obesity is a major problem in many societies, especially women. The purpose of this study was to investigate the effect of eight weeks of aerobic exercise with green coffee consumption on the levels of follistatin and myostatin in overweight women.

Methods: In this semi-experimental single blind Clinical Trial study, 30 overweight women were randomly divided into two groups (n=15), aerobic exercise (8-Weeks, 3days/Week, 20 min/day, at the last week 60 min/day) with green coffee and with placebo (daily). Blood samples were collected in the fasting morning before exercise and 48 hours after the last training session. After centrifugation, the samples were isolated, then for determine of gene expression, used the RT-PCR method and for the concentration of follistatin and myostatin based on ng/ml used ELISA method. Data were analysed by ANCOVA test and SPSS-22 software (p <0.05).

Results: Aerobic exercise combined with green coffee consumption significantly increase in follistatin expression (P= 0.004, F= 10.995) and a significant reduction in fat percentage in the both groups (P= 0.004, F= 9.809). There was no significant difference between the two groups on follistatin (P= 0.567, F= 0.34), but on the fat percentage, the difference between the two groups was significant (P= 0.0001, F=29.156). But there was no significant effect on myostatin and muscle mass in any group (P= 0.291, F= 1.182 and P= 0.745, F= 0.108).

Conclusion: The combination of aerobic exercise with green coffee can play an important role in weight loss and chronic diseases associated with obesity.
Keywords

1. Kim YJ, Kim KY, Kim MS, Lee JH, Lee KP, Park T. A mixture of the aqueous extract of Garcinia cambogia, soy peptide and L-carnitine reduces the accumulation of visceral fat mass in rats rendered obese by a high fat diet. J Genes Nutr. 2008; 2: 353-8.
2. Rector RS, Warner SO, Liu Y, et al. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Am J Physiol Endocrinol Metab. 2007; 293.
3. World health organization. Obesity and overweight statistics worldwide, Fact Sheet 311. Geneva: 2017.
4. Snyder EE, Walts B, Perusse L, Chagnon YC, Weisnagel SJ, Rankinen T, et al. The human obesity gene map: the 2003 update. Obes Res. 2004; 12: 369–439.
5. Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, Reed JM, et al. Myostatin activin receptor IIb and follistatin-like-3 gene expression was altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab. 2008; 294(5): e918–927.
6. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387(6628): 83.
7. Ricaud S, Vernus B, Duclos M, et al. Inhibition of autocrine secretion of myostatin enhances terminal differentiation in human rhabdomyosarcoma cells.Oncogene. 2003; 22(51): 8221–32.
8. Thomas M, Langley B, Berry C, et al. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem. 2000; 275(51): 40235–43.
9. Tsuchida K. Targeting myostatin for therapies against muscle-wasting disorders. Curr Opin Drug Discov Dev. 2008; 11: 487–494.
10. Fakhfakh R, Michaud A, Tremblay JP. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice. Mol Ther 2011; 19(1): 204–210.
11. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001; 98: 9306–9311.
12. Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 2009; 39: 283–296.
13. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 2002; 277: 40735–40741.
14. Hill JJ, Qiu Y, Hewick RM, Wolfman NM. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 2003; 17: 1144–1154.
15. Allen, D. L., Hittel, D. S. & McPherron, A. C. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med. Sci. Sports Exerc. 2011; 43: 1828–1835.
16. Hittel D S, Berggren J R, Shearer J, Boyle K, Houmard J A. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes. 2009; 58: 30–38.
17. Gorgens S W, Eckardt K, Jensen J, Drevon C A, Eckel J. Exercise and Regulation of Adipokine and Myokine Production. J Pro Molecular Bio Trans Sci. 2015. http://dx.doi.org/10.1016/bs.pmbts.2015.07.002. Elsevier Inc.
18. Makanji Y, Zhu J, Mishra R, Holmquist C, Wong WP, Schwartz NB, et al. Inhibin at 90: from discovery to clinical application, Endocrin Rev. 2014; 35(5): 747–794.
19. Dani C. Activins in adipogenesis and obesity. Int. J. Obes. 2013; 37(2): 163–166.
20. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev. Biol. 2004; 270: 19–30.
21. Thompson TB, Lerch TF, Cook RW, Woodruff TK, Jardetzky TS. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev Cell, 2005; 9: 535–543.
22. Dieli-Conwright CM, Spektor TM, Rice JC, Sattler FR, Schroeder ET. Influence of hormone replacement therapy on eccentric exercise induced myogenic gene expression in postmenopausal women. J Appli Physio. 2009; 107(5): 1381-8.
23. Aoki MS, Soares AG, Miyabara EH, Baptista IL, Moriscot AS. Expression of genes related to myostatin signaling during rat skeletal muscle longudinal growth. J Musc Ner. 2009; 40(6): 992-9.
24. Hansen, J. et al. Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine. Endocrinology. 2011; 152: 164–171.
25. Perakakis N, Mougios V, Fatouros I, Siopi A, Draganidis D, Peradze N, et al. Physiology of Activins /Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise. J Clin Endoc Metab, October 2018; 103(10): 3890–3899.
26. Hansen JS, Rutti S, Arous C, Clemmesen JO, Secher NH, Drescher A, Gonelle-Gispert C, Halban PA, Pedersen BK, Weigert C, Bouzakri K, Plomgaard P. Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio. J Clin Endocrinol Metab. 2016;101(2):550–560.
27. Anastasilakis AD, Polyzos SA, Skouvaklidou EC, Kynigopoulos G, Saridakis ZG, Apostolou A, et al. Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans. Metabolism. 2016;65(10):1459–1465.
28. Flanagan JN, Kristina L, et al. Role of Follistatin in Promoting Adipogenesis in Women. J Clin Endocrinol Metab, August 2009; 94(8): 3003–3009.
29.Vecera R, Zacharova A, Orolin J, Skottova N, Anzenbacher P. The effect of silymarin on expression of selected ABC transporters in the rat. J Veterinarni Medic 2011; 56: 59–62.
30. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C. Author links open overlay panel P. The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes. the CARDIO2000 case-control study. J Nutr 2003; 133: 3228-3232.
31. Butcher LR, Thomas A, Backx K, Roberts A, Webb R, Morris K. Low-Intensity Exercise Exerts Beneficial Effects on Plasma Lipids via PPARγ. Med Sci Sports Exerc. 2008; 40(7): 1263-70. 10.49/MSS.
32. Farah A, Donangelo CM. Phenolic compounds in coffee. Braz J Plant Physiol. 2006; 18: 23–36.
33. Arion WJ, Canfield WK, Ramos FC, Schindler PW, Burger HJ, Hemmerle H, et. al. Chlorogenic acid and hydroxy nitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys. 1997; 339: 315-322.
34. Graham TE. Caffeine, coffee and ephedrine: impact on exercise performance and metabolism. Can J Appl Physiol, 2001; 26(Suppl): S103-19.
35. Applegate E. Effective nutritional ergogenic aids. Int J Sport Nutr. 1999; 9(2): 229-39.
36. Shimoda H, Seki E, Aitani M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med. 2006; 6: 1–9.
37. Rahmati-Ahmadabad S, Ansari-Pirsaraei Z, Ghanbari-Niaki Aet al. Effect of 8 Weeks Treadmill Running with or without Pistachia Atlantica Liquid Extraction on Liver ABCG8 Gene Expression and Cholesterol Level in Female Rat. Iranian Journal of Health and Physical Activity 2012;3(1):43-9.
38. Bagheri L. Faramarzi M. Banitalebi E. Azamian Jazi A. The effect of sequence order of combined training (strength and endurance) on Myostatin, Follistatin and Follistatin/Myostatin ratio in older women. Sport Physio J. 1394; 26: 143-164. [Persian]
39. Diel P. Schiffer T, Geisleret S, al. Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive immuno PCR. J Molecu Cell Endocrin, 2010; 19-8.
40. Rashidlamir A, Attarzadeh S. R, Attarzadeh H, ,Hejazi K, Motevalli Anberani S. M. The effect of eight weeks resistance and aerobic training on myostatin and follistatin expression in cardiac muscle of rats. J Cardiovasc Thorac Res, 2016; 8(4): 164-169. [Persian]
41. Schiffer T, Geisler S, Sperlich B, Strüder H. MSTN mRNA after varying exercise modalies in humans. J Sports Med. 2011; 32(6): 683-7.
42. Hittel D S, Axelson M, Sarna N, Shearer J, Huffman K M, Kraus W E. Myostatin decreases wh aerobic exercise and associates wh insulin resistance. Med Sci Sports Exerc. 2010; 42(11): 2023.
43. Walker K S, Kambadur R, Sharma M, Smh H K. Resistance training alters plasma myostatin but not IGF-1 in healthy men. Med Sci Sports Exerc. 2004; 36(5): 787-93.
44. Dieli-Conwright CM, Spektor TM, Rice JC, Sattler FR, Schroeder ET. Hormone therapy and maximal eccentric exercise alters myostatin-related gene expression in postmenopausal women. J Strength Cond Res. 2012; 26: 1374–1382.
45. Saket A, Izad Dost F, Shabani R. The effect of combined exercise with green coffee consumption on serum levels of hormones, IGF-testosterone And cortisol in women overweight and obese. . J Neyshabur Univ Med Sci. 1396; 5(2): 15. [Persian].
46. Jason R, Beam A, Gibson L, Chad M, Kerksick, et al. Effect of post-exercise caffeine and green coffee bean extract consumption on blood glucose and insulin concentrations. J Nutr. 2015; 292–297.
47. Salimi, Taqiyan. Comparison of Effect of TRX and Green Coffee on the Level of Leptin and Adiponectin in Obese Women. [dissertation] Azad Univ Isfahan, Sport Sci. IRI.N.Doc and Lib. 1394. [Persian].
48. Milan G, Dalla Nora E, Pilon C, Pagano C, Granzotto M, Manco M, et al. Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab. 2004; 89(6): 2724–7.
49. Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. J Physiol Genomics. 2006; 27(2): 114–21.
50. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol. 2003 Oct;23(20):7230–42.
51. Gutierrez-Salmeana G, et al. Effects of Epicatechin on molecular modulators of skeletal muscle growth and differentiation. J Nutr Bioch. 2014; 91–94.
52. Mafi F, Biglari S, Ghardashi Afousi A, Gaeini AA. Epicatechin supplementation and resistance training-induced improvement of muscle strength and circulatory levels of plasma follistatin and myostatin in sarcopenic older adults. J Agi and Phys Act. 2019 Jun; 27(3): 384-391. doi: 10.1123/japa.2017-0389. Epub 2019 Feb 27.